A direct-to-consumer anti-aging supplement brand had built meaningful scale through a long-form VSL funnel — then lost most of it overnight when a domain migration reset audience learning and disrupted tracking. Most agencies would have called it creative fatigue and started over. SkyHouse diagnosed it as a structural problem, rebuilt methodically, and recovered 254% of lost spend while holding profitability.
The brand peaked at $1.06M/month at 1.50x ROAS in January 2026, then contracted to $196K/month by April after a domain migration disrupted tracking and reset Meta's purchase signal. SkyHouse was brought in to stabilize the account, identify which creative angles survived the transition, rebuild under a hard 1.75x ROAS target, and scale back toward peak spend. By August 2026, spend was at $694K/month with a confirmed 1.48x ROAS.
The team identified that older campaigns had been running on the old domain. These were consolidated and paused. New angle tests began immediately under the new domain: "Daughter," "Brands," "Stem Cells / Longevity," and "Sam Videos" — a video series with a named presenter format.
Two-track system running simultaneously:
Best single-angle ROAS: the "Toxins" angle — framing anti-aging as protection from environmental toxins rather than supplementation — achieved 1.79x ROAS in one week. Weekend campaigns running at ~$20K/weekend at 1.42x ROAS added a second revenue layer on top of the weekday base. Geographic expansion: winning domestic angles cloned to international audiences in May 2026.
Bid strategy inflection: shifted from direct CPA bidding to ROAS bidding at 1.75x — telling Meta to prioritize higher-value buyers, not just the cheapest conversions.
| Metric | Result | Timeframe |
|---|---|---|
| Spend Rebuild | +254% ($196K → $694K/mo) | Apr → Aug 2026 |
| Peak Weekly ROAS | 1.48x (week of Aug 19) | Aug 2026 |
| Best Single Angle ROAS | 1.79x (Top 5 Toxins / Japper) | Aug 2026 |
| Blended ROAS (engagement) | 1.75x | Nov 2025 – Sep 2026 |
| Revenue Generated | $7.4M | Nov 2025 – Sep 2026 |
| Total Spend Managed | $4.2M | Nov 2025 – Sep 2026 |
Data source: internal parquet pipeline. Attribution note: 3-way Meta/RedTrack/BigQuery reconciliation pending. ⚑ Needs Jason: BQ reconciliation + naming permission before public launch
A domain migration is not a creative problem — it's a structural problem that requires a structural solution. The right move was to recognize the signal loss early, consolidate spend on the one surviving funnel, wait for purchase signal to rebuild, and only then re-expand testing. Agencies that respond to a domain migration by launching 10 new creative tests just burn budget while Meta figures out who to show the ads to. Consolidation first. Expansion second.
Book a 30-minute strategy call. We'll review your current setup and tell you where the biggest opportunity is — creative, funnel, attribution, or all three.
We work with DTC health and supplement brands spending $10k/mo or more on Meta.